Nicole Morgan, NP
Nurse Practitioner · Grand Forks, NDNPI 1083100036
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.3%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Onmark, Inc. at 54.2% of the total. Among nurse practitioner clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $64.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Onmark, Inc.$4K
- AbbVie$1K
- Johnson & Johnson$146
- AstraZeneca$135
- Lilly USA, LLC$108
- Novartis$99
- plus $1K from 33 others
What the payments were for
- Travel & lodging$3,03146%
- Food & beverage$3,48553%
- Gifts$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Onmark, Inc. | 10 | $3,543 |
| AbbVie | 14 | $1,468 |
| Johnson & Johnson | 7 | $146 |
| AstraZeneca(2 entities) | 7 | $135 |
| Lilly USA, LLC | 6 | $108 |
| Novartis | 6 | $99 |
| Daiichi Sankyo Inc. | 5 | $97 |
| Tersera Therapeutics LLC | 2 | $63 |
| Pharmaessentia USA Corporation | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Merck | 3 | $49 |
| Sanofi | 1 | $48 |
| Eisai Inc. | 2 | $43 |
| ADC Therapeutics America, Inc. | 2 | $35 |
| Taiho Oncology, Inc. | 2 | $35 |
| Pharmacosmos Therapeutics Inc. | 2 | $34 |
| Deciphera Pharmaceuticals Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Stemline Therapeutics Inc. | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $28 |
| Azurity Pharmaceuticals, Inc. | 1 | $27 |
| Incyte Corporation | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Spectrum Pharmaceuticals Inc. | 1 | $22 |
| Tempus AI, Inc | 1 | $21 |
| Pharmaand GmbH | 1 | $19 |
| Novocure Inc. | 1 | $19 |
| EMD Serono, Inc. | 1 | $18 |
| Beigene USA, Inc. | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $17 |
| Beone Medicines USA, Inc. | 1 | $17 |
| Blue Earth Diagnostics | 1 | $17 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Geron Corporation | 1 | $15 |
| AVEO Pharmaceuticals, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
How this compares
$6,536 in reported general payments places this provider in the 95th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Grand Forks
- Marlie BorowiczGrand Forks$5K
- Caroline SchroederGrand Forks$3K
- Wade OlsonGrand Forks$3K
- Jennifer LaframboiseGrand Forks$2K
- Melissa HayesGrand Forks$1K
- Emily GreensteinFargo$271K
- Sarah MatchaFargo$17K
- Jana SuderFargo$16K
- Lisa ClairmontBismarck$15K
- Jenna KelschMinot$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.